Considerations for setting occupational exposure limits for novel pharmaceutical modalities-Reference-Cited by-同舟云学术

Considerations for setting occupational exposure limits for novel pharmaceutical modalities

Published:2020-12 Issue: Volume:118 Page:104813
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Graham Jessica C.,Hillegass Jedd,Schulze Gene

Funder

Bristol Myers Squibb

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference159 articles.

1. Occupational health categorization and compound handling practice systems—roots, application and future;Ader;J. Chem. Health Saf.,2005

2. Guideline on Setting Health Based Exposure Limits for Use in Risk Identification in the Manufacture of Different Medicinal Products in Shared Facilities;Agency,2014

3. Clinical expert panel on monitoring potential lung toxicity of inhaled oligonucleotides: consensus points and recommendations;Alton;Nucleic Acid Therapeut.,2012

4. Probody therapeutics: an emerging class of therapies designed to enhance on-target effects with reduced off-tumor toxicity for use in immuno-oncology;Autio;Clin. Canc. Res.,2020

5. Designer oncolytic adenovirus: coming of age;Baker;Cancers,2018

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics;Toxicology Letters;2024-09

2. Quantum-Mechanics Calculations Elucidate Skin-Sensitizing Pharmaceutical Compounds;Chemical Research in Toxicology;2024-07-29

3. “Build Your Own” ADC Mimics: Identification of Nontoxic Linker/Payload Mimics for HIC-Based DAR Determination, High-Throughput Optimization, and Continuous Flow Conjugation;Organic Process Research & Development;2024-07-17

4. Use of Impinging Jet to Improve Scalability in the Preparation of the ABBV-154 Drug-Linker;Organic Process Research & Development;2024-06-28

5. Development and Execution of a Scalable Route to an Immunology ADC Drug-Linker for ABBV-154;Organic Process Research & Development;2024-06-25